Alpha 1-Antitrypsin Deficiency research hub
4 indexed studies · 3 currently recruiting
- active not recruitingPHASE2
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
This study looks at a new long-term treatment called SAR447537 for adults with lung damage (emphysema) caused by a condition called Alpha-1 Antitrypsin Deficiency (AATD). It will check how safe and effective this treatment is over time.
United States · Australia · Denmark - recruitingNA
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
This study looks at a new treatment called Apreo BREATHE for people with severe emphysema, a type of COPD. It tests if inserting small devices into airways can help release trapped air and improve breathing, alongside usual care.
United States · Austria · Netherlands - recruitingNA
A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema
This study is testing a new implant called the IAB 50 Flex for people in the UK with severe emphysema, a type of serious lung disease. Doctors want to see if this implant can help them breathe better and improve their quality of life.
France · Netherlands - recruitingNA
The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema
This study looks at a new way to treat severe emphysema called ETLA. It aims to see if this treatment is safe and effective by shrinking parts of the lung that are over-inflated, helping people breathe better and improve their quality of life.
Austria · Germany · Netherlands